Elayne Chan-Penebre

943 total citations
4 papers, 298 citations indexed

About

Elayne Chan-Penebre is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, Elayne Chan-Penebre has authored 4 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 1 paper in Pathology and Forensic Medicine and 0 papers in Infectious Diseases. Recurrent topics in Elayne Chan-Penebre's work include Cancer-related gene regulation (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (1 paper). Elayne Chan-Penebre is often cited by papers focused on Cancer-related gene regulation (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (1 paper). Elayne Chan-Penebre collaborates with scholars based in United States. Elayne Chan-Penebre's co-authors include Robert A. Copeland, J. Joshua Smith, Richard Chesworth, Sarah K. Knutson, Scott Ribich, Heike Keilhack, Igor Feldman, Allison E. Drew, Maria Roche and John Campbell and has published in prestigious journals such as Molecular Cancer Therapeutics, Xenobiotica and ACS Medicinal Chemistry Letters.

In The Last Decade

Elayne Chan-Penebre

4 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elayne Chan-Penebre United States 4 260 83 41 24 16 4 298
Katie Holmes United States 6 242 0.9× 39 0.5× 56 1.4× 12 0.5× 6 0.4× 13 311
Joshua M. Eichhorn United States 6 177 0.7× 26 0.3× 94 2.3× 14 0.6× 15 0.9× 14 280
Candace Shelton United States 5 136 0.5× 44 0.5× 36 0.9× 11 0.5× 6 0.4× 5 161
Jorge Vaz Pinto Neto Brazil 4 107 0.4× 29 0.3× 50 1.2× 6 0.3× 5 0.3× 6 182
Mike R. Zou United States 5 327 1.3× 15 0.2× 69 1.7× 11 0.5× 4 0.3× 5 373
Tonći Šuštić Netherlands 7 192 0.7× 25 0.3× 72 1.8× 12 0.5× 3 0.2× 9 255
Robert Kassees United States 3 127 0.5× 21 0.3× 74 1.8× 5 0.2× 3 0.2× 6 162
Philippa Dudley United Kingdom 4 100 0.4× 27 0.3× 46 1.1× 10 0.4× 4 0.3× 5 154
Shunsheng Zheng China 8 395 1.5× 13 0.2× 93 2.3× 13 0.5× 8 0.5× 8 454
María Cortés-Sempere Spain 7 260 1.0× 17 0.2× 68 1.7× 10 0.4× 5 0.3× 8 305

Countries citing papers authored by Elayne Chan-Penebre

Since Specialization
Citations

This map shows the geographic impact of Elayne Chan-Penebre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elayne Chan-Penebre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elayne Chan-Penebre more than expected).

Fields of papers citing papers by Elayne Chan-Penebre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elayne Chan-Penebre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elayne Chan-Penebre. The network helps show where Elayne Chan-Penebre may publish in the future.

Co-authorship network of co-authors of Elayne Chan-Penebre

This figure shows the co-authorship network connecting the top 25 collaborators of Elayne Chan-Penebre. A scholar is included among the top collaborators of Elayne Chan-Penebre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elayne Chan-Penebre. Elayne Chan-Penebre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Drew, Allison E., Trupti Lingaraj, Natalie M. Warholic, et al.. (2017). EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL. Molecular Cancer Therapeutics. 16(11). 2586–2597. 52 indexed citations
2.
Chan-Penebre, Elayne, Kelli Armstrong, Allison E. Drew, et al.. (2017). Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models. Molecular Cancer Therapeutics. 16(5). 850–860. 127 indexed citations
3.
Rioux, Nathalie, Kenneth W. Duncan, Xiu‐Sheng Miao, et al.. (2015). Species differences in metabolism of EPZ015666, an oxetane-containing protein arginine methyltransferase-5 (PRMT5) inhibitor. Xenobiotica. 46(3). 268–277. 16 indexed citations
4.
Duncan, Kenneth W., Nathalie Rioux, P. Ann Boriack‐Sjodin, et al.. (2015). Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666. ACS Medicinal Chemistry Letters. 7(2). 162–166. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026